Migraine: References

1. Welch KM, Cutrer FM, Goadsby PJ. Migraine pathogenesis: Neural and vascular mechanisms. Neurology. 2003;60:9–14.

2. Martin VT, Behbehani MM. Headache: Towards a rational understanding of migraine trigger factors. Medical Clinics of North America. 2001;85:911–941.

3. Bolay H, Reuter U, Dunn AK, et al. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med. 2002;8:136–142.

4. Nappi G, Micielli G, Tassorelli C, et al. Effectiveness of piroxicam fast dissolving formulation sublingually administered in the symptomatic treatment of migraine without aura. Headache. 1993;33:296–300.

5. Chabriat H, Joire JE, Danchot J, et al. Combined oral lysine acetylsalicylate and metochopranide in the acute treatment of migraine: A multicenter double–blind placebo–controlled study. Cephalalgia. 1994;14:297–300.

6. Diamond S, Prager J, Freitag FG. Diet and headache: Is there a link? Postgraduate Medicine. 1986;79:279–286.

7. Egger J, Carter CM, Soothill JF, Wilson J. Oligoantigenic diet treatment of children with epilepsy and migraine. J Pediatr. 1989;114:51–58.

8. Monro J, Carini C, Brostoff J, Zilkha K. Food allergy in migraine. Study of dietary exclusion and RAST. Lancet. 1980;2:1–4.

9. Rasmussen BK. Epidemiology of headache. Cephalalgia. 2001;21:774–777.

10. Lamy C, Giannesini C, Zuber M, et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO–ASA Study. Atrial Septal Aneurysm. Stroke. 2002;33:706–711.

11. Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52:1622–1625.

12. Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right–to–left shunt on transcranial Doppler: a case–control study. Cerebrovasc Dis. 1998;8:327–330.

13. Tfelt–Hansen P, De Vries P, Saxena PR.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs. 2000;60:1259–1287.

14. Welch KM, Ellis DJ, Keenan PA. Successful migraine prophylaxis with naproxen sodium. Neurology. 1985;35:1304–1310.

15. Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia. 1998;18:704–708.

16. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butterbur) is an effective preventive treatment for migraine. Neurology. 2004;63:2240–2244.

17. Diener HC, Rahlfs VW, Danesch U. The first placebo–controlled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol. 2004;51:89–97.

18. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005;45:196–203.

19. Danesch U, Rittinghausen R. Safety of a patented special butterbur root extract for migraine prevention. Headache. 2003;43:76–78.

20. Pittler MH, Ernst E. Feverfew for preventing migraine. Cochrane Database Syst Rev. 2004;(1):CD002286.

21. Diener HC, Pfaffenrath V, Schnitker J, Friede M, Henneicke–von Zepelin HH. Efficacy and safety of 6.25 mg t.i.d. feverfew CO2–extract (MIG–99) in migraine prevention––a randomized, double–blind, multicentre, placebo–controlled study. Cephalalgia. 2005;25:1031–1041.

22. Jansen SC, van Dusseldorp M, Bottema KC, Dubois AE. Intolerance to dietary biogenic amines: a review. Ann Allergy Asthma Immunol. 2003;91:233–240.

23. Vaughan TR. The role of food in the pathogenesis of migraine headache. Clin Rev Allergy. 1994;12:167–180.

24. Mansfield LE, Vaughan TR, Waller SF, Haverly RW, Ting S. Food allergy and adult migraine: double–blind and mediator confirmation of an allergic etiology. Ann Allergy. 1985;55:126–129.

25. Barnard N. Foods That Fight Pain. New York: Harmony Books; 1998.

26. Egger J, Carter CM, Wilson J, Turner MW, Soothill JF. Is migraine food allergy? A double–blind controlled trial of oligoantigenic diet treatment. Lancet. 1983;2:865–869.

27. Millichap JG, Yee MM. The diet factor in pediatric and adolescent migraine. Pediatr Neurol. 2003;28:9–15.

28. Sinclair S. Migraine headaches: nutritional, botanical and other alternative approaches. Altern Med Rev. 1999;4:86–95.

29. Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low–fat diet on incidence and severity of migraine headaches. J Womens Health Gend Based Med. 1999;8:623–630.

30. Davis RJ, Murdoch CE, Ali M, et al. EP4 prostanoid receptor–mediated vasodilatation of human middle cerebral arteries. Br J Pharmacol. 2004;141:580–585.

31. LaMancusa R, Pulcinelli FM, Ferroni P, et al. Blood leukotrienes in headache: correlation with platelet activity. Headache. 1991;31:409–414.

32. Riccioni G, Di Ilio C, Conti P, Theoharides TC, D'Orazio N. Advances in therapy with antileukotriene drugs. Ann Clin Lab Sci. 2004;34:379–387.

33. Harel Z, Gascon G, Riggs S, Vaz R, Brown W, Exil G. Supplementation with omega–3 polyunsaturated fatty acids in the management of recurrent migraines in adolescents. J Adolesc Health. 2002;31:154–161.

34. Wagner W, Nootbaar–Wagner U. Prophylactic treatment of migraine with gamma–linolenic and alpha–linolenic acids. Cephalalgia. 1997;17:127–130

35. Boehnke C, Reuter U, Flach U, Schuh–Hofer S, Einhaupl KM, Arnold G. High–dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11:475–477.

36. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high–dose riboflavin in migraine prophylaxis. Neurology. 1998;50:466–470.

37. Mauskop A, Altura BT, Altura BM. Serum ionized magnesium levels and serum ionized calcium/ionized magnesium ratios in women with menstrual migraine. Headache. 2002;42:242–248.

38. Trauninger A, Pfund Z, Koszegi T, Czopf J. Oral magnesium load test in patients with migraine. Headache. 2002;42:114–119.

39. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double–blind, placebo–controlled study. Cephalalgia. 2002;22:345–353.

40. Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ. Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double–blind, placebo–controlled trial. Headache. 2003;43:601–610.

41. Black KL, Culp B, Madison D, et al. The protective effects of dietary fish oil on focal cerebral infarction. Prostaglandin Med. 1979;5:247–252.   

42. McCarren T, Hitzemann R, Smith R et al: Amelioration of severe migraine by fish oil (omega–3) fatty acids. Am J Clin Nutr 1985; 41:874 [abstract].

43. Pradalier A, Bakouche P, Baudesson G, et al. Failure of omega–3 polyunsaturated fatty acids in prevention of migraine: a double–blind study versus placebo. Cephalalgia. 2001;21:818–822.

44. Rapoport AM, Bigal ME. Migraine preventive therapy: current and emerging treatment options. Neurol Sci. 2005;26 (suppl 2):S111–120S.

45. Titus F, Davalos A, Alom J, Codina A. 5–Hydroxytryptophan versus methysergide in the prophylaxis of migraine. Randomized clinical trial. Eur Neurol.1986;25:327–329.

46. Awada A, al Jumah M. The first–of–Ramadan headache. Headache. 1999;39:490–493.

47. Sjaastad O, Bakketeig LS. Caffeine–withdrawal headache. The Vaga study of headache epidemiology. Cephalalgia. 2004;24:241–249.

48. Hering–Hanit R, Gadoth N. Caffeine–induced headache in children and adolescents. Cephalalgia. 2003;23:332–335.